<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: huntington</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Researchers find potential treatment for Huntington's disease (w/ Video)</title>
   	 <description>Investigators at Burnham Institute for Medical Research, the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease.</description>
     <link>http://www.physorg.com/news177515236.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 15 Nov 2009 13:48:15 EST</pubDate>
	 <guid isPermaLink="false">news177515236</guid>
</item>
<item>
     <title>Researchers show efficacy of gene therapy in mouse models of Huntington's disease</title>
   	 <description>Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.</description>
     <link>http://www.physorg.com/news176126406.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 30 Oct 2009 13:01:53 EST</pubDate>
	 <guid isPermaLink="false">news176126406</guid>
</item>
<item>
     <title>Transplanted neurons develop disease-like pathology in Huntington's patients</title>
   	 <description>The results of a recent study published in PNAS question the long-term effects of transplanted cells in the brains of patients suffering from Huntington's disease. This study, conducted jointly by Dr. Francesca Cicchetti of Universit&amp;eacute; Laval in Quebec, Canada, Dr. Thomas B. Freeman of the University of South Florida, USA, and colleagues provides the first demonstration that transplanted cells fail to offer a long-term replacement for degenerating neurons in patients with Huntington's disease.</description>
     <link>http://www.physorg.com/news167330808.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 18:50:01 EST</pubDate>
	 <guid isPermaLink="false">news167330808</guid>
</item>
<item>
     <title>Researchers gain insight into mechanism underlying Huntington's</title>
   	 <description>Researchers at the University of Kentucky Markey Cancer Center and Graduate Center for Toxicology (GCT) have gained new insight into the genetic mechanisms underlying Huntington's disease and other neurodegenerative or neuromuscular disorders caused by trinucleotide repeats (or TNRs) in DNA.</description>
     <link>http://www.physorg.com/news166711425.html</link>
	 <category>Biology</category>
	 <pubDate>Mon, 13 Jul 2009 13:44:27 EST</pubDate>
	 <guid isPermaLink="false">news166711425</guid>
</item>
<item>
     <title>Mystery solved: Tiny protein-activator responsible for brain cell damage in Huntington disease</title>
   	 <description>Johns Hopkins brain scientists have figured out why a faulty protein accumulates in cells everywhere in the bodies of people with Huntington's disease (HD), but only kills cells in the part of the brain that controls movement, causing negligible damage to tissues elsewhere. The answer, reported this week in Science, lies in one tiny protein called "Rhes" that's found only in the part of the brain that controls movement. The findings, according to the Hopkins scientists, explain the unique pattern of brain damage in HD and its symptoms, as well as offer a strategy for new therapy.</description>
     <link>http://www.physorg.com/news163344119.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Jun 2009 14:22:40 EST</pubDate>
	 <guid isPermaLink="false">news163344119</guid>
</item>
<item>
     <title>New hope for treatment of neurodegenerative disorder</title>
   	 <description>Researchers from the University of Southern California have taken an important first step toward protecting against Huntington disease using gene therapy.</description>
     <link>http://www.physorg.com/news159461715.html</link>
	 <category>Chemistry</category>
	 <pubDate>Mon, 20 Apr 2009 15:55:41 EST</pubDate>
	 <guid isPermaLink="false">news159461715</guid>
</item>
<item>
     <title>Researchers Link Huntington Depression to Genetics</title>
   	 <description>(PhysOrg.com) -- The depression experienced by people with Huntington disease (HD) may have nothing to do with the emotional stress of knowing you have a devastating, incurable disorder, according to a University of British Columbia study published in the journal Brain. </description>
     <link>http://www.physorg.com/news159200198.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 17 Apr 2009 15:17:47 EST</pubDate>
	 <guid isPermaLink="false">news159200198</guid>
</item>
<item>
     <title>Huntington disease begins to take hold early on</title>
   	 <description>A global analysis of brain proteins over a 10-week period in a mouse model of Huntington Disease has revealed some new insights into this complex neurodegenerative disorder. For example, profound changes (comparable to those seen in late-stage HD) actually occur well before any disease symptoms show up, and most of the changes are confined to a specific stage during disease progression. These findings should aid in determining the optimal times for therapies that aim to treat or cure this disease.</description>
     <link>http://www.physorg.com/news159115703.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Apr 2009 15:48:50 EST</pubDate>
	 <guid isPermaLink="false">news159115703</guid>
</item>
<item>
     <title>Researchers describe molecular 'two-step' leading to protein clumps of Huntington's disease</title>
   	 <description>In a paper published in the early online version of Nature Structural and Molecular Biology, researchers at the University of Pittsburgh School of Medicine deconstruct the first steps in an intricate molecular dance that might lead to the formation of pathogenic protein clumps in Huntington's disease, and possibly other movement-related neurological disorders.</description>
     <link>http://www.physorg.com/news155749490.html</link>
	 <category>Biology</category>
	 <pubDate>Sun, 08 Mar 2009 16:45:59 EST</pubDate>
	 <guid isPermaLink="false">news155749490</guid>
</item>
<item>
     <title>Old gastrointestinal drug slows aging</title>
   	 <description>Recent animal studies have shown that clioquinol - an 80-year old drug once used to treat diarrhea and other gastrointestinal disorders - can reverse the progression of Alzheimer's, Parkinson's and Huntington's diseases. Scientists, however, had a variety of theories to attempt to explain how a single compound could have such similar effects on three unrelated neurodegenerative disorders.</description>
     <link>http://www.physorg.com/news150483871.html</link>
	 <category>Chemistry</category>
	 <pubDate>Tue, 06 Jan 2009 17:04:31 EST</pubDate>
	 <guid isPermaLink="false">news150483871</guid>
</item>


</channel>
</rss>

